Cargando…
Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day
BACKGROUND: The inhaled corticoteroid (ICS) ciclesonide (Cic), controls asthma symptoms in the majority of patients at the recommended dose of 160 µg/day. However, the relationship between the level of asthma control and increasing doses of Cic is unknown. This study investigated whether long-term t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349703/ https://www.ncbi.nlm.nih.gov/pubmed/28331346 http://dx.doi.org/10.2147/JAA.S111712 |